Home Transfers and Retained Life Estates

A retained life estate is created by deed. The current owner — the 'life tenant' — conveys the property to one or more 'remaindermen' (typically adult children), but the deed reserves to the life tenant the exclusive right to possess, use, and enjoy the property for the remainder of the life tenant's life. At the life tenant's death, the remainder interest ripens into full ownership automatically; no probate, no court order, no transfer document — the death certificate plus the recorded deed are the only documents the chain of title requires.

New York recognizes the retained life estate as a form of present transfer with a future interest. Under EPTL Article 6 and the common law of estates in land, the life tenant has the right to occupy the property, to collect rent if the property is leased, and to receive the income from any portion of the property. The life tenant is responsible for property taxes, ordinary maintenance, mortgage interest, and ordinary repairs. The remaindermen are responsible for extraordinary repairs and improvements that benefit the future interest, though in practice families negotiate these costs informally.

Critically, the life tenant cannot sell or mortgage the property unilaterally. Any conveyance after the deed is recorded requires the joinder of every remainderman; if even one remainderman refuses, the property is effectively frozen until the life tenant's death. This is the most consequential limitation of the retained life estate compared with a Medicaid Asset Protection Trust, where a successor trustee retains administrative flexibility.

Under Social Services Law § 366 and federal law at 42 USC § 1396p, the transfer of a remainder interest in real estate is treated as a partial gift for Medicaid lookback purposes. The Medicaid agency, using actuarial tables published by the Department of Health, calculates the value of the retained life estate versus the value of the remainder interest based on the life tenant's age at the time of transfer. Only the remainder-interest value is treated as the uncompensated transfer; the life-estate value is treated as a retained asset.

The 60-month institutional Medicaid lookback (five years under SSL § 366) begins on the date the deed is recorded. If the life tenant applies for nursing-home Medicaid before sixty months pass, the value of the gifted remainder interest creates a transfer penalty — calculated by dividing the gift value by the regional monthly cost of care to produce a number of months of Medicaid ineligibility. After sixty months, the gift is no longer in the lookback window and no transfer penalty applies.

Medicaid estate recovery operates differently for a retained life estate. At the life tenant's death, the life estate itself terminates — there is nothing for the estate to own. The remainderman's interest, having existed since the deed was recorded, is not part of the deceased life tenant's probate estate. New York's estate recovery (limited by federal law to the probate estate under current state policy) therefore cannot reach the property. This recovery-protection feature is one of the principal reasons families use the retained life estate at all.

At the life tenant's death, the property receives a full stepped-up basis under IRC § 1014. Because the life tenant retained a sufficient interest to cause inclusion of the entire property value in their gross estate under IRC § 2036, the entire fair market value at death — not just the value of the life estate — becomes the new basis in the hands of the remaindermen. If the remaindermen sell shortly after death, capital gain on the appreciation that accrued during the life tenant's ownership is washed away. This is a meaningful tax benefit and a major advantage over an outright lifetime gift.

During the life tenant's lifetime, sale of the property triggers more complex capital gain analysis. The IRC § 121 primary-residence exclusion ($250,000 single, $500,000 married) is available only to the extent of the life tenant's retained interest, not the remaindermen's interest. The remaindermen pay capital gain on their share of the appreciation since the deed was recorded. This is why we counsel against retained life estates where a lifetime sale is foreseeable; the tax cost of a sale during the life tenant's life is significantly worse than under a Medicaid Asset Protection Trust.

Property tax exemptions generally survive a transfer to a retained life estate. The STAR and Enhanced STAR exemptions, senior-citizen exemptions, and veterans' exemptions all turn on the life tenant's continued occupancy and meet the statutory requirements when the life tenant remains in the home. Confirm with the local assessor at the time of transfer because filing requirements vary by jurisdiction.

The two tools achieve the same headline result — removal of the family home from the Medicaid five-year lookback after sixty months pass — but they differ in three important ways. First, control. A MAPT names a trustee (typically an adult child) who can sell, refinance, or lease the property without the joinder of every beneficiary; a retained life estate requires unanimous remainderman consent for any sale. Second, flexibility for future changes. A MAPT can be drafted with limited powers of appointment, sprinkle provisions, and trustee discretion; a retained life estate is fixed at the moment the deed is signed.

Third, the income-tax treatment of a lifetime sale. A grantor-trust MAPT preserves the life tenant's full IRC § 121 primary-residence exclusion on a lifetime sale because the grantor is treated as the owner for income tax purposes. A retained life estate fragments the exclusion between life tenant and remaindermen, often producing significantly worse tax outcomes.

The retained life estate has its own advantages. It is much cheaper to set up — a deed costs a fraction of drafting and funding an irrevocable trust. It is simpler to explain. And the recorded deed is its own evidence of the transfer, with no separate trust agreement to be lost or misinterpreted. For families with a single property, no near-term sale planned, full alignment among the children, and no concerns about creditor protection, the retained life estate remains a defensible choice.

We recommend a retained life estate when the client owns a single property, intends to remain in it for the rest of their life, has fully aligned adult children, and wants the simplest and cheapest tool that achieves probate avoidance and starts the Medicaid lookback. The client must accept that the property cannot be sold or refinanced without unanimous remainderman consent — an acceptable trade in many family configurations.

We recommend a MAPT when the client owns multiple properties, when a lifetime sale or refinance is foreseeable, when one or more remaindermen are minors or have creditor concerns of their own, when the client wants to retain flexibility to change beneficiaries over time, or when full IRC § 121 exclusion on a lifetime sale matters to the family's tax planning. The MAPT is more expensive at creation but pays back the cost through the operational flexibility it provides over the next twenty or thirty years.

We recommend neither tool when the planning horizon is shorter than sixty months and institutional Medicaid is imminent. In that scenario, the analysis shifts to crisis-Medicaid tools — spousal refusal, promissory-note plans, exempt-asset conversions, and pooled income trusts — none of which depend on the five-year lookback being clear. The retained life estate and the MAPT are pre-need planning tools; they reward families who plan five years or more in advance.